Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia

European Journal of Clinical Pharmacology

Volumn 60, Issue 11, 2005, Pages 791-795

  Li, Kun Yan ^a   Li, Xin ^b   Cheng, Ze Neng ^b   Zhang, Bi Kui ^b   Peng, Wen Xing ^b   Li, Huan De ^b  

^a HUNAN CANCER HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Erythromycin; Interaction; Metabolism; Quetiapine

Indexed keywords

ERYTHROMYCIN; QUETIAPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG METABOLISM; FEMALE; GASTROINTESTINAL TOXICITY; HALF LIFE TIME; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DIBENZOTHIAZEPINES; ERYTHROMYCIN; FEMALE; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 15444377221     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0853-x     Document Type: Article

References (11)

1. McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE(2000) Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 61:252-260
2. Arvanitis LA, Miller BG (1997) Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 42:233-246
3. King DJ (1998) Drug treatment of the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 8:33-42
4. Nemeroff CB, Kinkead B, Goldstein J (2002) Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry 63(suppl 13):5-11
5. DeVane CL, Nemeroff CB (2001) Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 40:509-522
6. 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. Psychopharmacology (Berl) 135:119-126
7. Dev V, Raniwalla J (2000) Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf 23:295-307
8. Wong YW, Yeh C, Thyrum PT (2001) The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 21:89-93
9. Cooper KJ, Martin PD, Dane AL, Warwick MJ, Raza A, Schneck DW (2003) The effect of erythromycin on the pharmacokinetics of rosuvastatin. Eur J Clin Pharmacol 59:51-56
10. Psychiatry department of Chinese medical association (ed) (2001) Chinese criteria of mental disease, 3rd edn. Shandong Science & Technology Press, Jinan, pp 75-78
11. Li KY, Cheng ZN, Li X, Bai XL, Zhang BK, Wang F, Li HD (2004) Simultaneous determination of quetiapine and three metabolites in human plasma by high-performance liquid chromatography - electrospray ionization mass spectrometry. Acta Pharmacol Sin 25:110-114